Zhu Wei, Wang Bao, Zhou Shengbin, Liu Hong
CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, P. R. China.
Beilstein J Org Chem. 2015 Sep 14;11:1624-31. doi: 10.3762/bjoc.11.177. eCollection 2015.
A novel strategy for the construction of the phthalazin-1(2H)-one scaffold has been developed by means of a copper-mediated cascade C-H/C-H coupling and intramolecular annulations and a subsequent facile hydrazinolysis. This C-H activation transformation proceeds smoothly with wide generality, good functional tolerance and high stereo- and regioselectivity under mild conditions. Through the removal of the directing group, the resulting moiety could easily be transformed into the phthalazin-1(2H)-one scaffold, which is known to be a privileged moiety and a bioactive nucleus in pharmaceuticals.
通过铜介导的级联C-H/C-H偶联和分子内环化以及随后简便的肼解反应,开发了一种构建酞嗪-1(2H)-酮骨架的新策略。这种C-H活化转化在温和条件下顺利进行,具有广泛的通用性、良好的官能团耐受性以及高立体和区域选择性。通过去除导向基团,所得部分可轻松转化为酞嗪-1(2H)-酮骨架,该骨架在药物中是一种具有优势的部分和生物活性核心。